https://www.aacr.org/patients-caregivers/progress-against-cancer/her2-targeting-therapy-for-her2-ultralow-breast-cancer/
HER2-targeting Therapy for HER2-ultralow Breast Cancer | Research | AACR
Feb 11, 2025 - The FDA has approved fam-trastuzumab deruxtecan-nxki (also called T-DXd) as a treatment for certain HER2-low or HER2-ultralow breast cancers.
breast cancer researchtargetingtherapyaacr
https://www.selectscience.net/article/denovix-launches-first-all-in-one-spectrophotometer-fluorometer-system-at-aacr
DeNovix Launches First All-in-One Spectrophotometer / Fluorometer System at AACR
all in onedenovixlaunchesfirstspectrophotometer
https://ecancer.org/en/news/1680-aacr-2011-scientists-identify-kras-rearrangements-in-metastatic-prostate-cancer
AACR 2011: Scientists identify KRAS rearrangements in metastatic prostate cancer - ecancer
Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are published in C
metastatic prostate canceraacrscientistsidentifykras
https://third-news.com/article/2e05add2-3abf-11f1-aaeb-9ca3ba0a67df
Antengene Launches Innovative ADC and TCE Programs at AACR 2026 Conference - Third News
At AACR 2026, Antengene introduced advanced ADC and TCE programs, showcasing its commitments to innovative cancer therapies.
third newslaunchesinnovativeadctce
https://www.biospace.com/press-releases/step-pharma-to-spotlight-work-in-ctps2-null-solid-tumours-at-2025-eortc-nci-aacr-international-conference-on-molecular-targets-and-cancer-therapeutics
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International...
solid tumourssteppharmaspotlightwork
https://exhibitorsdata.com/product/aacr-annual-meeting-exhibitor-list/
AACR Annual Meeting Exhibitor List - Buy At $250 - Exhibitors Data
Buy At $250 - The AACR Annual Meeting 2026 is where the latest cancer breakthroughs are shared. Connect with top researchers and experts via our AACR Annual...
annual meetingexhibitor listbuy ataacrexhibitors
https://www.prnewswire.com/news-releases/aacr-2021-immvira-presents-the-preclinical-study-results-of-mvr-t3011-via-intravenous-administration-301271625.html
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration
/PRNewswire/ -- On April 15, 2021, ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration through publication in a...
preclinical studyresults ofaacrpresentsmvr
https://www.gov.uk/administrative-appeals-tribunal-decisions/jmcg-v-devon-partnership-nhs-trust-2017-ukut-348-aac
JMcG v Devon Partnership NHS Trust: [2017] UKUT 348 (AAC) ; [2018] AACR 11 - GOV.UK
Upper Tribunal Administrative Appeals Chamber decision by Judge Knowles on 23 August 2017.
nhs trustgov ukdevonpartnershipaac
https://www.benzinga.com/general/biotech/26/02/50489409/agenus-to-highlight-new-data-at-aacr-io-exploring-systemic-and-tumor-inflammation-biomarkers-with
Agenus To Highlight New Data At AACR-IO Exploring Systemic And Tumor Inflammation Biomarkers With...
Feb 9, 2026 - Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology, today announced that new translational and clinical biomarker analyses from its botensilimab (BOT)...
new datahighlightaacrioexploring
https://nanoporetech.com/zh/about/events/conferences/cancer-san-diego
Oxford Nanopore at AACR 2026 | Oxford Nanopore Technologies
Oxford Nanopore Technologies are exhibiting and presenting at AACR in April.
oxford nanoporeaacrtechnologies
https://diariodeavisos.elespanol.com/canariasenred/tag/aacr/
AACR | Canariasenred - Noticias de Canarias
noticias de canariasaacr
https://worldhealthcarereport.com/article/807198005-precede-biosciences-presents-data-at-aacr-2025-demonstrating-ability-to-resolve-gene-expression-for-thousands-of-tumor-specific-genes-from-a-simple
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for...
gene expressionprecedebiosciencespresentsdata
https://ecrcentral.org/fundings/aacr-bayer-stimulating-therapeutic-advancements-through-research-training-start-grants/
AACR Bayer Stimulating Therapeutic Advancements through Research Training (START) Grants |...
Funding opportunity: AACR Bayer Stimulating Therapeutic Advancements through Research Training (START) Grants. View eligibility, deadlines, and how to apply.
research trainingaacrbayerstimulatingtherapeutic
https://oncodaily.com/voices/eortc-nci-aacr-485041
Registrations and Abstract Submissions Are Open for EORTC-NCI-AACR 2026 Symposium - OncoDaily
submissions are openregistrationsabstracteortcnci
https://www.merckmillipore.com/AR/es/20180323_002007
Event | AACR Annual Meeting 2021 | Merck
Whether you are looking to improve cancer detection or enhance your understanding of tumor biology, we want to empower your research by providing the tools and...
annual meetingeventaacrmerck
https://www.brightsurf.com/news/19NQX6R1/aacr-announces-2026-distinguished-service-award-recipients.html
AACR announces 2026 Distinguished Service Award recipients | BrightSurf Science News
The American Association for Cancer Research (AACR) is recognizing Senator Susan Collins and Jill Feldman with the 2026 Distinguished Public Service Award and...
distinguished service awardscience newsaacrannouncesrecipients
https://mediamedic.co/aacr-2026-qilu-pharmaceutical-showcases-12-innovative-programs-on-the-global-stage-a-comprehensive-overview-of-adcs-tces-small-molecule-inhibitors-and-a-precision-oncology-portfolio/?php%20echo%20wp_logout_url(%20home_url()%20);%20?
AACR 2026 | Qilu Pharmaceutical Showcases 12 Innovative Programs on the Global Stage: A...
May 3, 2026 - At the recently concluded 2026 Annual Meeting of the American Association for Cancer Research (AACR), Qilu Pharmaceutical presented 12 innovative oncology...
innovative programson theglobal stageaacrqilu
https://www.nfcr.org/blog/16-nfcr-supported-researchers-featured-in-the-forefront-of-cancer-research-at-aacr-2023/
16 NFCR-Supported Researchers Featured at AACR 2023
Dec 2, 2025 - National Foundation for Cancer Research supported researchers to be featured at AACR 2023 - further demonstrating our commitment to a cure!
featured atsupportedresearchersaacr